📰 Lieping Chen News
Lieping Chen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lieping Chen. Real-time updates on events, politics, business and more.
September 12, 2023
• Data presented at the 2023 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Singapore BELTSVILLE, Md., Sept. 12, 2023 -- NextCure,...
July 10, 2023
BOSTON & WEST HAVEN, Conn.--(BUSINESS WIRE)--Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv...
October 26, 2022
Normunity has raised $65m in Series A financing round for expanding the frontier of precision immuno-oncology with immune normaliser therapies.
October 25, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 28, 2022
T cells, biology textbooks teach us, are the soldiers of the immune system, constantly on the ready to respond to a variety of threats, from viruses to tumors.
May 27, 2022
Without rest and maintenance, T cells can die and leave their hosts more susceptible to pathogens, Yale scientists report.
October 15, 2021
Milwaukee, WI (PRWEB) October 15, 2021 -- The Society for Immunotherapy of Cancer (SITC) has announced the inaugural class ofFellows of the Academy of
April 27, 2021
Serap Aksoy, Hui Cao, Lieping Chen, and Debra Fischer were elected to the academy, one of the highest honors bestowed on a U.S. scientist or engineer.